Fund detail
Sands Capital Management
large-active, growth, lo
Quarters
52
2018-09-30
$35.36B
Positions
68
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SAREPTA THERAPEUTICS INC SRPT | $307.1M | 0.87% | 1,901,564 | +1,901,564 | 2018-09-30 | $162 | ~$162 | +0.00% | |||
| 2 | ABIOMED INC ABMDEUR | $199.5M | 0.56% | 443,607 | +443,607 | 2018-09-30 | $450 | ~$450 | +0.00% | |||
| 3 | HUTCHISON CHINA MEDITECH LTD HCM | $16.4M | 0.05% | 508,275 | +508,275 | 2018-09-30 | $32 | ~$32 | +0.00% | |||
| 4 | BEIGENE LTD ONC | $16.2M | 0.05% | 93,843 | +93,843 | 2018-09-30 | $172 | ~$172 | +0.00% | |||
| 5 | EVENTBRITE INC EB4 | $9.6M | 0.03% | 251,880 | +251,880 | 2018-09-30 | $38 | ~$38 | +0.00% |